Our TCR-T cell therapies at OncoVanta Therapeutics are designed to be scalable, allowing us to meet the diverse needs of patients efficiently. This scalability not only makes our therapies accessible to a wider population but also ensures that we can adapt to the evolving landscape of cancer treatment. By streamlining production processes, we can deliver timely therapies that provide real hope to patients facing challenging diagnoses. This means faster access to groundbreaking treatments and an increased chance for patients to reclaim their lives from cancer.